MedTrace Logo

Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC

NCT04638959 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2020-11-20

No results posted yet for this study

Summary

In this clinical trial, we aim to explore the synergistic alteration of specific bacteria both in gastric mucosas and feces of gastric cancer patients for the method of non-invasive and cost-effective faecal marker detection. We aim to select and validate specific microbes as noninvasive, accurate, simple, sensitive and highly-accepted biomarkers that might assist to screen and diagnose gastric cancer, especially early gastric cancer patients.

Conditions

  • Non-invasive and Sensitive Faecal Bacterial Markers for Early Screening and Diagnosis of Gastric Cancer

Interventions

OTHER

collect gastric tissue and stool samples

collect gastric tissue and stool samples

Sponsors & Collaborators

  • Shanghai Changzheng Hospital

    collaborator OTHER

  • Ruijin Hospital

    collaborator OTHER

  • Jing'an District Central Hospital of Shanghai

    collaborator UNKNOWN

  • Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

    collaborator OTHER

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Seventh Medical Center of PLA Army General Hospital

    collaborator OTHER

  • The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

    collaborator OTHER

  • Zhongshan Hospital Xiamen University

    collaborator OTHER

  • Tianjin Medical University General Hospital

    collaborator OTHER

  • Shanghai Jiao Tong University School of Medicine

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-09-30
Primary Completion
2021-03-31
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638959 on ClinicalTrials.gov